As of 3:43pm ET
| -0.025 / -0.94%|
The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 10.50, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate represents a +300.00% increase from the last price of 2.63.
The current consensus among 6 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.